S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Ritter Pharmaceuticals SEC Filings & 10K Form (NASDAQ:RTTR)

$0.29
-0.01 (-3.37 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$0.28
Now: $0.29
$0.31
50-Day Range
$0.24
MA: $0.52
$1.21
52-Week Range
$0.23
Now: $0.29
$1.85
Volume179,903 shs
Average Volume597,624 shs
Market Capitalization$2.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15

SEC Filings

Ritter Pharmaceuticals (NASDAQ:RTTR) SEC Filings

DateFilerForm TypeView
10/15/2019
3:15 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
4:27 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
3:30 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:00 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:12 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:45 PM
Ritter Pharmaceuticals (Filer)
Form 424B3
08/01/2019
11:20 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
08/01/2019
11:15 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
07/25/2019
8:18 AM
Ritter Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/24/2019
4:29 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
4:10 PM
Ritter Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/11/2019
4:22 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:48 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:15 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:06 PM
Ritter Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
5:10 AM
Ritter Pharmaceuticals (Filer)
Form DEFA14A
04/26/2019
5:05 AM
Ritter Pharmaceuticals (Filer)
Form DEF 14A
04/01/2019
5:21 AM
Ritter Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2019
8:25 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
6:00 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:31 PM
Alyeska Investment Group, L.P. (Filed by)
Ritter Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2019
3:27 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:23 PM
Doyle Noah (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:13 PM
MAIER PAUL V (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:09 PM
Beck John W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:04 PM
Ritter Ira E. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
2:56 PM
Ritter Andrew J (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
4:00 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
5:02 AM
Ritter Pharmaceuticals (Filer)
Form 424B3
12/02/2018
11:15 PM
Ritter Pharmaceuticals (Filer)
Form EFFECT
11/20/2018
8:57 PM
Ritter Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/09/2018
8:01 AM
Ritter Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2018
6:10 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
7:07 PM
Ritter Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
11/07/2018
5:24 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
10:57 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
4:27 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
1:19 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4/A
08/20/2018
4:19 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2018
7:05 PM
Ritter Andrew J (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2018
4:21 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2018
5:11 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2018
4:25 PM
Beck John W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
4:23 PM
Beck John W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/25/2018
3:05 PM
Ritter Pharmaceuticals (Filer)
Form DEFA14A
05/15/2018
5:10 AM
Ritter Pharmaceuticals (Filer)
Form DEF 14A
05/07/2018
5:03 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
3:37 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2018
10:42 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2018
5:44 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2018
5:34 AM
Ritter Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2018
2:26 PM
Alyeska Investment Group, L.P. (Filed by)
Ritter Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
3:31 PM
BAKER BROS. ADVISORS LP (Filed by)
Ritter Pharmaceuticals (Subject)
Form SC 13G
01/25/2018
8:31 PM
PROEHL GERALD T (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:25 PM
Doyle Noah (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:23 PM
MAIER PAUL V (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:18 PM
FOEHR MATTHEW W (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:15 PM
Merino William M. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:10 PM
Ritter Pharmaceuticals (Issuer)
Step Michael D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:05 PM
Ritter Andrew J (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
8:00 PM
Ritter Ira E. (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2018
7:57 PM
Benjamin Jeffrey S (Reporting)
Ritter Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2018
1:30 PM
Ritter Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/20/2017
4:17 PM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2017
5:20 AM
Ritter Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2017
5:15 AM
Ritter Pharmaceuticals (Filer)
Form DEF 14A
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: What is a blue-chip stock?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel